Smoking Cessation Intervention for Neoplasms, Malignant

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Neoplasms, Malignant+4 More
Smoking Cessation Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at whether a mobile app can help people quit smoking. The app is based on a computer program that has helped people quit smoking in the past.

Eligible Conditions
  • Neoplasms, Malignant
  • Smoke
  • Cigarette Smokers
  • Current Smokers

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Up to 5 weeks

Up to 5 weeks
Adaptation of the programmatic infrastructure of WebCASSI (Computer Assisted Stop Smoking Intervention for the World Wide Web) into a more-portable table and smartphone application (app) that will be available both in English and Spanish
Pre-testing of the app

Trial Safety

Trial Design

1 Treatment Group

Prevention (smoking reduction, Quitting Schedule mobile app)
1 of 1
Experimental Treatment

19 Total Participants · 1 Treatment Group

Primary Treatment: Smoking Cessation Intervention · No Placebo Group · N/A

Prevention (smoking reduction, Quitting Schedule mobile app)Experimental Group · 4 Interventions: Internet Mobile Technology, Smoking Cessation Intervention, Interview, Questionnaire Administration · Intervention Types: Other, Behavioral, Other, Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention
2005
N/A
~1630

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 weeks

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
12,989 Previous Clinical Trials
41,299,039 Total Patients Enrolled
119 Trials studying Neoplasms, Malignant
1,054,257 Patients Enrolled for Neoplasms, Malignant
M.D. Anderson Cancer CenterLead Sponsor
2,779 Previous Clinical Trials
1,785,000 Total Patients Enrolled
31 Trials studying Neoplasms, Malignant
21,781 Patients Enrolled for Neoplasms, Malignant
Paul CinciripiniPrincipal InvestigatorM.D. Anderson Cancer Center
3 Previous Clinical Trials
3,021 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing to download and use the app.
You are willing to set a quit smoking date within 5 weeks of enrollment.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 29th, 2021

Last Reviewed: October 15th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.